These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27898072)

  • 21. Impaired modulation of attention and emotion in schizophrenia.
    Dichter GS; Bellion C; Casp M; Belger A
    Schizophr Bull; 2010 May; 36(3):595-606. PubMed ID: 18843096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study.
    Ham BJ; Sung Y; Kim N; Kim SJ; Kim JE; Kim DJ; Lee JY; Kim JH; Yoon SJ; Lyoo IK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):403-11. PubMed ID: 17141385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
    Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
    J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency.
    Fu CH; Suckling J; Williams SC; Andrew CM; Vythelingum GN; McGuire PK
    Am J Psychiatry; 2005 Mar; 162(3):485-94. PubMed ID: 15741465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.
    Deicken RF; Zhou L; Schuff N; Weiner MW
    Schizophr Res; 1997 Oct; 27(1):65-71. PubMed ID: 9373896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated brain lactate responses to neural activation in panic disorder: a dynamic 1H-MRS study.
    Maddock RJ; Buonocore MH; Copeland LE; Richards AL
    Mol Psychiatry; 2009 May; 14(5):537-45. PubMed ID: 18180759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippocampal and frontolimbic function as intermediate phenotype for psychosis: evidence from healthy relatives and a common risk variant in CACNA1C.
    Erk S; Meyer-Lindenberg A; Schmierer P; Mohnke S; Grimm O; Garbusow M; Haddad L; Poehland L; Mühleisen TW; Witt SH; Tost H; Kirsch P; Romanczuk-Seiferth N; Schott BH; Cichon S; Nöthen MM; Rietschel M; Heinz A; Walter H
    Biol Psychiatry; 2014 Sep; 76(6):466-75. PubMed ID: 24411473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of altered membrane phospholipid metabolism in the anterior cingulate cortex and striatum of patients with bipolar disorder I: A multi-voxel (1)H MRS study.
    Cao B; Stanley JA; Selvaraj S; Mwangi B; Passos IC; Zunta-Soares GB; Soares JC
    J Psychiatr Res; 2016 Oct; 81():48-55. PubMed ID: 27376506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.
    Ohrmann P; Kugel H; Bauer J; Siegmund A; Kölkebeck K; Suslow T; Wiedl KH; Rothermundt M; Arolt V; Pedersen A
    Schizophr Res; 2008 Dec; 106(2-3):156-63. PubMed ID: 18799290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
    Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
    Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of metabolite changes in response to a varying visual stimulation paradigm using short-TE
    Mekle R; Kühn S; Pfeiffer H; Aydin S; Schubert F; Ittermann B
    NMR Biomed; 2017 Feb; 30(2):. PubMed ID: 28008663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiome and magnetic resonance spectroscopy study of subjects at ultra-high risk for psychosis may support the membrane hypothesis.
    He Y; Kosciolek T; Tang J; Zhou Y; Li Z; Ma X; Zhu Q; Yuan N; Yuan L; Li C; Jin K; Knight R; Tsuang MT; Chen X
    Eur Psychiatry; 2018 Sep; 53():37-45. PubMed ID: 29870894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.
    Théberge J; Bartha R; Drost DJ; Menon RS; Malla A; Takhar J; Neufeld RW; Rogers J; Pavlosky W; Schaefer B; Densmore M; Al-Semaan Y; Williamson PC
    Am J Psychiatry; 2002 Nov; 159(11):1944-6. PubMed ID: 12411236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional neuroimaging abnormalities in youth with psychosis spectrum symptoms.
    Wolf DH; Satterthwaite TD; Calkins ME; Ruparel K; Elliott MA; Hopson RD; Jackson CT; Prabhakaran K; Bilker WB; Hakonarson H; Gur RC; Gur RE
    JAMA Psychiatry; 2015 May; 72(5):456-65. PubMed ID: 25785510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal 4.0 Tesla (31)P magnetic resonance spectroscopy changes in the anterior cingulate and left thalamus in first episode schizophrenia.
    Miller J; Williamson P; Jensen JE; Manchanda R; Menon R; Neufeld R; Rajakumar N; Pavlosky W; Densmore M; Schaefer B; Drost DJ
    Psychiatry Res; 2009 Aug; 173(2):155-7. PubMed ID: 19520552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study.
    Chou PH; Koike S; Nishimura Y; Kawasaki S; Satomura Y; Kinoshita A; Takizawa R; Kasai K
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():63-9. PubMed ID: 24275075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
    Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral dysfunctions of emotion-cognition interactions in adolescent-onset schizophrenia.
    Pauly K; Seiferth NY; Kellermann T; Backes V; Vloet TD; Shah NJ; Schneider F; Habel U; Kircher TT
    J Am Acad Child Adolesc Psychiatry; 2008 Nov; 47(11):1299-310. PubMed ID: 18827725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.